COLISTIMIXIN PHEBRA colistimethate sodium 1million IU powder for nebuliser solution vial

Active ingredient:

colistimethate sodium, Quantity: 1 million IU

Available from:

Phebra Pty Ltd

INN (International Name):

Colistimethate sodium

Pharmaceutical form:

Inhalation

Composition:

Excipient Ingredients:

Administration route:

Inhalation

Units in package:

30 vial

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Colistimixin Phebra powder for nebuliser solution is indicated for the treatment of colonisation and infections of the lung due to susceptible Pseudomonas aeruginosa in patients with cystic fibrosis. Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Product summary:

Visual Identification: White to off-white powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2014-04-02